This article was originally published in PharmaVoice.
Clinical outcome assessment data provided by clinical trial participants can be, well, subjective. What may be of concern for one participant, may be of no concern to the other. This ambiguity of data can hinder that effectiveness of the data collected in some clinical trials. Introducing sensors and wearables in these trials can improve the quality of data by recording objective insights, supplementary to participant self-reported outcomes.
In this article, Bill Byrom, VP of Product Strategy and Innovation here at Signant Health, shares what some of these sensor and wearable technologies are, how they can be implemented effectively in clinical trials, and which types of trials can benefit the most from their use. Read on to learn more.